Medicus Pharma Ltd.
MDCX.V
TSX
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
8/18/2026
-
TipRanks
8/18/2026
-
The Cerbat Gem
8/17/2026
-
TipRanks: TheFly
8/17/2026
-
TipRanks: TheFly
8/14/2026
-
TipRanks
8/14/2026
-
TipRanks
8/13/2026
-
Proactive Investors - UK
8/13/2026
-
The Cerbat Gem
8/13/2026
-
Proactive Investors - UK
8/12/2026
-
TipRanks
8/12/2026
-
ACCESS Newswire
8/3/2026
-
Globe Newswire
8/1/2026
-
Proactive Investors - UK
7/31/2026
-
Proactive Investors - UK
7/31/2026
-
Proactive Investors - UK
7/31/2026
-
TipRanks: TheFly
7/31/2026
-
Globe Newswire
7/31/2026
-
Benzinga
Analysts' Opinions Are Mixed on These Healthcare Stocks: Incyte (INCY) and Medicus Pharma Ltd (MDCX)
7/28/2026
-
TipRanks
7/28/2026
-
TipRanks: TheFly
7/27/2026
-
Globe Newswire
7/18/2026
-
Proactive Investors - UK
7/17/2026
-
The Cerbat Gem
7/17/2026
-
Proactive Investors - UK
7/16/2026
-
Proactive Investors - UK
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, August 12, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
610 636 0184
Address
300 Conshohocken State Road
Suite 200
West Conshohocken, PA 19428
Suite 200
West Conshohocken, PA 19428
Country
Year Founded
Business Description
Sector
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in...
more